Zynerba pharmaceuticals inc.

Major-Pharmaceuticals

ZYNE


80 West Lancaster Avenue
Devon , PA 19333

Executive/
Director

Price

  • Last Close
  • $ 1.3
    $ +0.03 2.36 %
    Oct 10, 2023
  • 52-Week High/Low
  • $1.39 - $1.21
  • YTD
  • 0%

  • Trading Volume
  • 862,786
  • Market Cap Full
  • $ 70.1M
  • Shares Outstanding
  • 53.9M
    Aug 9, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -6.2% 28.9% -30.6% 82.5% -5% 40.9% -32.3% -18.9% - -
Q2 -27.5% -15.6% 22.1% 145.7% 4% 13.8% -43.7% -24.2% - -
Q3 90.5% -50.7% -15.9% -46.8% 8% -19.9% -35.8% 289.6% - -
Q4 19.5% 44.1% -62.2% -22.5% -0.3% -29.5% -27.6% 2.4% - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%55%-20%-76%94%-43%-9%-82%145%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022
Q1 0.49 0.60 -0.91 -0.47 -0.53 -0.2 -0.21
Q2 0.70 0.64 -0.89 -0.5 -0.78 -0.25 -0.24
Q3 0.67 0.63 -0.47 -0.08 -0.31 -0.26 -0.2
Q4 0.71 0.60 -0.34 -0.45 -0.28 -0.24 -0.17
A 2.6 2.5 -2.6 -1.5 -1.9 -1 -0.8

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 21.1 23.6 41.3 42.4 53.4
Jun 13.6 21.1 25 41.3 43.6 53.7
Sep 17.6 23.2 29.3 41.3 45.8 53.9
Dec 17.6 23.2 29.4 41.2 47.1 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - 52 34 -
Equity multiplier - - - - -